Provided by Tiger Trade Technology Pte. Ltd.

Ayala Pharmaceuticals, Inc.

0.6036
0.0000
Volume:- -
Turnover:- -
Market Cap:25.71M
PE:-0.08
High:0.6036
Open:0.6036
Low:0.6036
Close:0.6036
52wk High:0.8010
52wk Low:0.0011
Shares:42.59M
Float Shares:18.10M
Volume Ratio:- -
T/O Rate:- -
Dividend:- -
Dividend Rate:- -
EPS(TTM):-7.9866
EPS(LYR):-7.9866
ROE:-392.03%
ROA:-181.05%
PB:-1.05
PE(LYR):-0.08

Loading ...

Company Profile

Company Name:
Ayala Pharmaceuticals, Inc.
Exchange:
EXPERT
Establishment Date:
- -
Employees:
- -
Office Location:
- -
Zip Code:
- -
Phone:
- -
Fax:
- -
Introduction:
Ayala Pharmaceuticals, Inc., a clinical-stage oncology company, primarily focuses on developing and commercializing small molecule therapeutics for people living with rare tumors and aggressive cancers. It is also developing proprietary Lm-based antigen delivery products for patients suffering from common cancers. The company's lead candidates under development are AL102, which targets the aberrant activation of the Notch pathway with gamma secretase inhibitors to treat various tumors, including desmoid tumors; and ADXS-504, a Lm-based therapy for early-stage prostate cancer. Ayala Pharmaceuticals, Inc. was founded in 2017 and is based in Monmouth Junction, New Jersey.